Vycor Financial Statements From 2010 to 2024
| VYCO Stock | USD 0.07 0 1.47% |
Check Vycor Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vycor Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vycor financial statements analysis is a perfect complement when working with Vycor Medical Valuation or Volatility modules.
Vycor |
Vycor Medical OTC Stock Return On Asset Analysis
Vycor Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Vycor Medical Return On Asset | -0.24 |
Most of Vycor Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vycor Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Vycor Medical has a Return On Asset of -0.2385. This is 97.27% lower than that of the Health Care Equipment & Supplies sector and 98.68% lower than that of the Health Care industry. The return on asset for all United States stocks is 70.36% higher than that of the company.
Vycor Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vycor Medical's current stock value. Our valuation model uses many indicators to compare Vycor Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vycor Medical competition to find correlations between indicators driving Vycor Medical's intrinsic value. More Info.Vycor Medical is rated first in return on asset category among its peers. It is rated first in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vycor Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vycor Medical's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Vycor Medical Financial Statements
Vycor Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Vycor OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Vycor Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 6 people.
Pair Trading with Vycor Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vycor Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Vycor OTC Stock
| 0.48 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
The ability to find closely correlated positions to Vycor Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vycor Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vycor Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vycor Medical to buy it.
The correlation of Vycor Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vycor Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vycor Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vycor Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.